News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
155 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
2 (25)
3 (172)
4 (158)
5 (196)
6 (68)
9 (168)
10 (111)
11 (155)
12 (151)
13 (101)
16 (193)
17 (121)
18 (134)
19 (128)
20 (79)
23 (123)
24 (139)
25 (89)
26 (95)
27 (155)
30 (184)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
30
Press Releases
Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)
September 11, 2024
·
3 min read
Press Releases
Bristol Myers Squibb Announces Dividend Payable on November 1, 2024
September 11, 2024
·
1 min read
Press Releases
‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
September 11, 2024
·
9 min read
Press Releases
Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU)
September 11, 2024
·
23 min read
Press Releases
Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study
September 11, 2024
·
20 min read
Press Releases
Astellas Presents Scientific Progress in Advanced and Hard-to-Treat Cancers at ESMO 2024
September 11, 2024
·
7 min read
Press Releases
Closed Loop Medicine Appoints Luba Greenwood as Chair of the Board of Directors
September 11, 2024
·
3 min read
Press Releases
Nxera Pharma’s Partner Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers
September 11, 2024
·
4 min read
Press Releases
Xencor Announces Pricing of $175 Million Public Offering of Common Stock
September 11, 2024
·
4 min read
Press Releases
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC
September 11, 2024
·
9 min read
Previous
14 of 16
Next
